Literature DB >> 28101401

Human heart failure biomarker immunosensor based on excessively tilted fiber gratings.

Binbin Luo1, Shengxi Wu2, Zhonghao Zhang2, Wengen Zou3, Shenghui Shi3, Mingfu Zhao3, Nianbing Zhong3, Yong Liu4, Xue Zou3, Lingling Wang2, Weina Chai5, Chuanmin Hu6, Lin Zhang7.   

Abstract

A label-free immunosensor platform based on excessively tilted fiber gratings (Ex-TFGs) was developed for highly specific and fast detection of human N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is considered a powerful biomarker for prognosis and risk stratification of heart failure (HF). High-purity anti-NT-proBNP monoclonal antibodies (MAbs) prepared in our laboratory were immobilized on fiber surface through the staphylococcal protein A (SPA) method for subsequent specific binding of the targeted NT-proBNP. Utilizing fiber optic grating demodulation system (FOGDS), immunoassays were carried out in vitro by monitoring the resonance wavelength shift of Ex-TFG biosensor with immobilized anti-NT-proBNP MAbs. Lowest detectable concentration of ~0.5ng/mL for NT-proBNP was obtained, and average sensitivity for NT-proBNP at a concentration range of 0~1.0 ng/mL was approximately 45.967 pm/(ng/mL). Several human serum samples were assessed by the proposed Ex-TFG biomarker sensor, with high specificity for NT-proBNP, indicating potential application in early diagnosing patients with acute HF symptoms.

Entities:  

Keywords:  (060.2370) Fiber optics sensors; (170.0170) Medical optics and biotechnology; (280.1415) Biological sensing and sensors

Year:  2016        PMID: 28101401      PMCID: PMC5231315          DOI: 10.1364/BOE.8.000057

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  21 in total

1.  Optic sensors of high refractive-index responsivity and low thermal cross sensitivity that use fiber Bragg gratings of >80 degrees tilted structures.

Authors:  Kaiming Zhou; Lin Zhang; Xianfeng Chen; Ian Bennion
Journal:  Opt Lett       Date:  2006-05-01       Impact factor: 3.776

2.  Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions.

Authors:  Katrin Schmitt; Bernd Schirmer; Christian Hoffmann; Albrecht Brandenburg; Patrick Meyrueis
Journal:  Biosens Bioelectron       Date:  2006-11-27       Impact factor: 10.618

3.  Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.

Authors:  Concetta Prontera; Gian Carlo Zucchelli; Simona Vittorini; Simona Storti; Michele Emdin; Aldo Clerico
Journal:  Clin Chim Acta       Date:  2008-10-26       Impact factor: 3.786

4.  Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA.

Authors:  Lynley K Lewis; Sara D Raudsepp; Timothy G Yandle; Christopher M Frampton; Suetonia C Palmer; Richard W Troughton; A Mark Richards
Journal:  Clin Biochem       Date:  2012-12-04       Impact factor: 3.281

Review 5.  How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.

Authors:  Jenny A Doust; Eva Pietrzak; Annette Dobson; Paul Glasziou
Journal:  BMJ       Date:  2005-03-19

6.  Protein A isolated from Staphylococcus aureus after digestion with lysostaphin.

Authors:  J Sjöquist; B Meloun; H Hjelm
Journal:  Eur J Biochem       Date:  1972-09-25

7.  The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.

Authors:  Karina R Seferian; Natalia N Tamm; Alexander G Semenov; Kadriya S Mukharyamova; Anastasya A Tolstaya; Ekaterina V Koshkina; Andrei N Kara; Mihail I Krasnoselsky; Fred S Apple; Tatiana V Esakova; Vladimir L Filatov; Alexey G Katrukha
Journal:  Clin Chem       Date:  2007-03-23       Impact factor: 8.327

8.  Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis.

Authors:  Tjebbe W Galema; Sing-Chien Yap; Marcel L Geleijnse; Robert J van Thiel; Jan Lindemans; Folkert J ten Cate; Jolien W Roos-Hesselink; Ad J J C Bogers; Maarten L Simoons
Journal:  J Am Soc Echocardiogr       Date:  2007-07-12       Impact factor: 5.251

9.  Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection.

Authors:  Reza Saber; Selma Mutlu; Erhan Pişkin
Journal:  Biosens Bioelectron       Date:  2002-09       Impact factor: 10.618

10.  Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers.

Authors:  P O Collinson; S C Barnes; D C Gaze; G Galasko; A Lahiri; R Senior
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

View more
  4 in total

1.  Zeolite-iron oxide nanocomposite from fly ash formed a 'clubbell' structure: integration of cardiac biocapture macromolecules in serum on microelectrodes.

Authors:  Zhiqiang Liu; Subash C B Gopinath; Zhifang Wang; Yibo Li; Periasamy Anbu; Wenlong Zhang
Journal:  Mikrochim Acta       Date:  2021-05-15       Impact factor: 5.833

Review 2.  Immunosensing Based on Optical Fiber Technology: Recent Advances.

Authors:  Maria Simone Soares; Miguel Vidal; Nuno F Santos; Florinda M Costa; Carlos Marques; Sónia O Pereira; Cátia Leitão
Journal:  Biosensors (Basel)       Date:  2021-08-30

3.  Optimization of Cladding Diameter for Refractive Index Sensing in Tilted Fiber Bragg Gratings.

Authors:  Sanzhar Korganbayev; Marzhan Sypabekova; Aida Amantayeva; Álvaro González-Vila; Christophe Caucheteur; Paola Saccomandi; Daniele Tosi
Journal:  Sensors (Basel)       Date:  2022-03-15       Impact factor: 3.576

4.  Relevance of the Spectral Analysis Method of Tilted Fiber Bragg Grating-Based Biosensors: A Case-Study for Heart Failure Monitoring.

Authors:  Miguel Vidal; Maria Simone Soares; Médéric Loyez; Florinda M Costa; Christophe Caucheteur; Carlos Marques; Sónia O Pereira; Cátia Leitão
Journal:  Sensors (Basel)       Date:  2022-03-10       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.